References
- Storms WW. Minimal persistent inflammation, on emerging concept in the nature and treatment of allergic rhinitis: the possible role of leukotrienes. Ann Allergy Asthma Immunol 2003; 91 131–140
- Giprandi G, Buscaglia S, Pesce G, et al. Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and acute allergy. J allergy clin Immunol 1995; 96:971–979.
- Passalagua G, Canonica GW. Impact of rhinitis on airway inflammation: biological and therapeutic impications. Respir Res 2001; 2 320–323
- Ricca V, Landi M, Ferrero P, et al. J Allergy Clin Immunol 2000; 105:54–57.
- Pssalacqua G, Guerra L, Licenzioto M, et al. ACI International 2003; 15:105–109.
- Simons FER. Allergic Rhinobronchitis: the asthma—allergic rhinitis link. J Allergy Clin Immunol. 1994; 104:534–540.
- Passalancqua G, Ciprandi G, Canonica GW. The nose-lung interaction: United airways disease. CURR Op Allergy Clin Immunol 2001; 1:7–14
- Djukanovich R, Asthma: A disease of inflammation and repair. J Allergy Clin Immunol 2000; 105: S522–S526.
- ISAAC. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema. Lancet 1998; 351 1225–1232
- Kapsali T, Horowitz E, Togias A. Rhinitis is ubiquitous in allergic asthmatics. J Allergy Clin Immunol 1999; 99:S139
- Meltzer EO, Malmstroni K, Lu S, et al. Concomitant moutelukast and loratidine as treatment for seasonal allergic rhinitis: a randomized, placebo controlled clinical trial. J Allergy Clin Immunol 2000; 105:917–922.
- Juliasson S, Pipkoru U, Karlsson G, et al. Mast cells and eosinophils in the allergic mucosal response to allergen challenge: changes in distribution and signs of activation in relation tosymptoms. J Allergy Clin Immunol 1992; 90:898–909.
- Steinchilber D, Radmark O, Samuelsson B. Transforming growth factor beta upregulates 5—lipoxygenace acticity during myeloid cell maturation. Proc Natl Acad Sci USA 1993; 90 5984–5988
- Robinson DS, Damiar, Zeibecoglou K, et al. CD 34 +/interleukin—5R x messenger RNA + cells in the bronchial mucosa in asthma: potential airway eosinophil progenitors. AM J Respir Cell Mol Biol 1999; 20:9–13.
- Pynaert G, Grooten J, Van Deventer SJ, et al. Cysteinyl leukotrienes mediate histamine hypersensitivity ex vivo by increasing histamine receptor numbers. Mol Med 1999; 5:685–692.
- Geredo K, Larson EB. Evidence-based diagnostic strategies for evaluation suspected allergic rhinitis. Ann Itern Med 2004; 140: 278–289.
- Day J, Corrilo T. Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis. J Allergy Clin Immunol 1998; 102 902–908
- Melzer EO, Grant JA. Impact of cetirizime on the burden of allergic rhinitis. Ann Allergy Asthma Immunol 1999; 83: 455–463.
- Bousquet J, van Vouwenberge P, Khaltoaiv N, et al. Allergic rhinitis and its impact on asthma. In collaboration with the World Health Organization. Executive summary of the workshop report. 7–10 December 1999; Geneva, Switzerland Allergy 2002,57 841–855
- Van Vouwenberge P, Bachert C, Passlacques G, et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 2000; 85:382–384.